Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations

Mireille C. Melles; Johannes C. C. M. In 't Veen; Dirk-jan Slebos; Frits M. E. Franssen; Marlies Van Dijk; Pieter-paul W. Hekking

doi:10.1111/all.70300

Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations

Mireille C. Melles^*
, Johannes C. C. M. In 't Veen
, Dirk-jan Slebos
, Frits M. E. Franssen
, Marlies Van Dijk
, Pieter-paul W. Hekking

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Number of pages	3
Journal	Allergy
DOIs	https://doi.org/10.1111/all.70300
Publication status	Published - 1 Mar 2026

Keywords

biologics
biomarkers
COPD
eosinophils
inflammation

Access to Document

10.1111/all.70300Licence: CC BY-NC

Cite this

@article{83025b00623f4df0b7cafe0c2ed8bb28,

title = "Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations",

keywords = "biologics, biomarkers, COPD, eosinophils, inflammation",

author = "Melles, \{Mireille C.\} and Veen, \{Johannes C. C. M. In 't\} and Dirk-jan Slebos and Franssen, \{Frits M. E.\} and \{Van Dijk\}, Marlies and Hekking, \{Pieter-paul W.\}",

year = "2026",

month = mar,

day = "1",

doi = "10.1111/all.70300",

language = "English",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations

AU - Melles, Mireille C.

AU - Veen, Johannes C. C. M. In 't

AU - Slebos, Dirk-jan

AU - Franssen, Frits M. E.

AU - Van Dijk, Marlies

AU - Hekking, Pieter-paul W.

PY - 2026/3/1

Y1 - 2026/3/1

KW - biologics

KW - biomarkers

KW - COPD

KW - eosinophils

KW - inflammation

U2 - 10.1111/all.70300

DO - 10.1111/all.70300

M3 - Comment/Letter to the editor

SN - 0105-4538

JO - Allergy

JF - Allergy

ER -